首页 > 最新文献

Digestive Endoscopy最新文献

英文 中文
A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease 建立新型严重程度标准的多中心观察研究,包括内镜评估肠道beharret病。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-27 DOI: 10.1111/den.70041
Toshiro Fukui, Makoto Naganuma, Yohei Kirino, Reiko Kunisaki, Yohei Mikami, Nobuhiro Ueno, Junji Umeno, Shigeki Bamba, Makoto Ooi, Shuhei Hosomi, Takayuki Matsumoto, Katsuyoshi Matsuoka, Chikako Watanabe, Masakazu Nagahori, Motoi Uchino, Kenji Watanabe, Fumihito Hirai, Minoru Matsuura, Yoshiya Tanaka, Mitsuhiro Takeno, Tadakazu Hisamatsu

Objective

This study aimed to establish a novel severity classification for intestinal Behçet's disease (BD) (SCIBD) and validate its criteria across multiple institutions.

Methods

Five parameters, including abdominal pain, tenderness, intestinal bleeding, serum C-reactive protein (CRP) level, and endoscopic findings, were identified to assess the severity of intestinal BD. Disease severity was categorized into remission and mild, moderate, or severe disease based on the criteria of each factor. This study also evaluated the correlation among the SCIBD scale, serum biomarkers, former disease activity for intestinal BD (DAIBD), and treatment decisions.

Results

A total of 146 patients with intestinal BD and simple ulcers were retrospectively enrolled from 14 institutions between April and November 2022. As SCIBD severity increased, CRP and DAIBD levels significantly increased, whereas serum albumin levels decreased in the whole population. Similar correlations have been observed even in patients with intestinal BD. Antitumor necrosis factor-alpha treatment was also significantly more common in severe cases (49.4%) than in moderate cases (20.8%; p = 0.001). However, the proportion of patients requiring corticosteroids was comparable between the moderate and severe disease groups (39.6% vs. 33.3%). In addition, no significant differences were observed in the frequency of corticosteroid treatment, anti-TNF-α treatment, or surgery among the four groups: quiescent, mild, moderate, and severe cases of DAIBD. SCIBD was changed after treatment with corticosteroids and TNF-α according to improving clinical, biological, and endoscopic findings.

Conclusions

The severity assessment of intestinal BD using our novel criteria correlated with appropriate treatment decisions, prognosis prediction, and treatment responses.

目的:本研究旨在建立一种新的肠behet病(BD) (SCIBD)严重程度分类,并在多个机构验证其标准。方法:采用腹痛、压痛、肠出血、血清c反应蛋白(CRP)水平和内镜检查结果等5个指标评估肠道BD的严重程度,并根据各因素的标准将疾病严重程度分为缓解、轻度、中度和重度。本研究还评估了SCIBD量表、血清生物标志物、肠道BD前疾病活动性(DAIBD)和治疗决策之间的相关性。结果:在2022年4月至11月期间,回顾性研究了来自14个机构的146例肠道BD和单纯性溃疡患者。随着SCIBD严重程度的增加,CRP和DAIBD水平显著升高,而整个人群的血清白蛋白水平下降。甚至在肠道BD患者中也观察到类似的相关性。抗肿瘤坏死因子- α治疗在严重病例(49.4%)中也明显比在中度病例(20.8%,p = 0.001)中更常见。然而,需要皮质类固醇的患者比例在中度和重度疾病组之间具有可比性(39.6%对33.3%)。此外,在四组:静止、轻度、中度和重度DAIBD病例中,皮质类固醇治疗、抗tnf -α治疗或手术的频率没有显著差异。经皮质类固醇和TNF-α治疗后,SCIBD根据临床、生物学和内窥镜检查结果的改善而改变。结论:使用我们的新标准评估肠道双相障碍的严重程度与适当的治疗决策、预后预测和治疗反应相关。
{"title":"A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease","authors":"Toshiro Fukui,&nbsp;Makoto Naganuma,&nbsp;Yohei Kirino,&nbsp;Reiko Kunisaki,&nbsp;Yohei Mikami,&nbsp;Nobuhiro Ueno,&nbsp;Junji Umeno,&nbsp;Shigeki Bamba,&nbsp;Makoto Ooi,&nbsp;Shuhei Hosomi,&nbsp;Takayuki Matsumoto,&nbsp;Katsuyoshi Matsuoka,&nbsp;Chikako Watanabe,&nbsp;Masakazu Nagahori,&nbsp;Motoi Uchino,&nbsp;Kenji Watanabe,&nbsp;Fumihito Hirai,&nbsp;Minoru Matsuura,&nbsp;Yoshiya Tanaka,&nbsp;Mitsuhiro Takeno,&nbsp;Tadakazu Hisamatsu","doi":"10.1111/den.70041","DOIUrl":"10.1111/den.70041","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study aimed to establish a novel severity classification for intestinal Behçet's disease (BD) (SCIBD) and validate its criteria across multiple institutions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Five parameters, including abdominal pain, tenderness, intestinal bleeding, serum C-reactive protein (CRP) level, and endoscopic findings, were identified to assess the severity of intestinal BD. Disease severity was categorized into remission and mild, moderate, or severe disease based on the criteria of each factor. This study also evaluated the correlation among the SCIBD scale, serum biomarkers, former disease activity for intestinal BD (DAIBD), and treatment decisions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 146 patients with intestinal BD and simple ulcers were retrospectively enrolled from 14 institutions between April and November 2022. As SCIBD severity increased, CRP and DAIBD levels significantly increased, whereas serum albumin levels decreased in the whole population. Similar correlations have been observed even in patients with intestinal BD. Antitumor necrosis factor-alpha treatment was also significantly more common in severe cases (49.4%) than in moderate cases (20.8%; <i>p</i> = 0.001). However, the proportion of patients requiring corticosteroids was comparable between the moderate and severe disease groups (39.6% vs. 33.3%). In addition, no significant differences were observed in the frequency of corticosteroid treatment, anti-TNF-α treatment, or surgery among the four groups: quiescent, mild, moderate, and severe cases of DAIBD. SCIBD was changed after treatment with corticosteroids and TNF-α according to improving clinical, biological, and endoscopic findings.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The severity assessment of intestinal BD using our novel criteria correlated with appropriate treatment decisions, prognosis prediction, and treatment responses.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145180601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence-Assisted Whole Slide Image Analysis for Lymph Node Status Prediction in Early Colorectal and Gastric Cancer 人工智能辅助全切片图像分析在早期结、胃癌淋巴结状态预测中的应用。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-27 DOI: 10.1111/den.70042
Katsuro Ichimasa, Shin-ei Kudo, Yuta Kouyama, Yuki Takashina, Hyunsoo Chung, Yasuharu Maeda, Wai Phyo Lwin, Yosuke Toya, Waku Hatta, Jimmy Bok Yan So, Khay Guan Yeoh, Tetsuo Nemoto, Masashi Misawa

With the widespread use of advanced endoscopic techniques such as endoscopic submucosal dissection, an increasing number of early colorectal cancer (T1 CRC) and early gastric cancer (EGC) cases are now treated with endoscopic resection as the first-line approach. However, the risk of lymph node metastasis (LNM)—approximately 10% in T1 CRC and 5%–10% in EGC—necessitates additional surgical resection in high-risk cases. Current guideline-based risk stratification depends on pathological evaluation of the resected specimens to determine whether further surgery is needed. Yet both T1 CRC and EGC face shared challenges in LNM risk prediction, particularly in terms of accuracy and reproducibility. This review focuses on the latter. The diagnosis of key pathological risk factors, which serve as predictors of LNM, is subject to considerable interobserver variability among pathologists. One potential solution is the application of artificial intelligence (AI)-assisted whole slide image (WSI) analysis, which has been gaining attention in recent studies. AI-assisted models for LNM prediction in T1 CRC and EGC have shown encouraging results, suggesting that WSI-based AI could offer a pathologist-independent strategy to improve diagnostic consistency. However, the field remains in an early stage, with key limitations including small sample sizes and limited external validation. Additional high-quality evidence will be needed to support clinical implementation. Addressing challenges such as stain standardization and image artifacts will also be critical for achieving regulatory approval and broader clinical adoption.

随着内镜粘膜下剥离等先进内镜技术的广泛应用,越来越多的早期结直肠癌(T1 CRC)和早期胃癌(EGC)患者将内镜切除作为一线治疗方法。然而,淋巴结转移(LNM)的风险- T1 CRC约为10%,egc为5%-10% -需要在高危病例中进行额外的手术切除。目前基于指南的风险分层取决于切除标本的病理评估,以确定是否需要进一步手术。然而,T1 CRC和EGC在LNM风险预测方面都面临着共同的挑战,特别是在准确性和可重复性方面。本文的重点是后者。作为LNM预测因子的关键病理危险因素的诊断,在病理学家之间存在相当大的观察者差异。一种潜在的解决方案是人工智能(AI)辅助全幻灯片图像(WSI)分析的应用,这在最近的研究中得到了广泛的关注。人工智能辅助模型用于T1 CRC和EGC的LNM预测已经显示出令人鼓舞的结果,这表明基于wsi的人工智能可以提供一种独立于病理学家的策略来提高诊断的一致性。然而,该领域仍处于早期阶段,主要局限包括样本量小和有限的外部验证。需要更多的高质量证据来支持临床实施。解决诸如染色标准化和图像伪影等挑战对于获得监管批准和更广泛的临床应用也至关重要。
{"title":"Artificial Intelligence-Assisted Whole Slide Image Analysis for Lymph Node Status Prediction in Early Colorectal and Gastric Cancer","authors":"Katsuro Ichimasa,&nbsp;Shin-ei Kudo,&nbsp;Yuta Kouyama,&nbsp;Yuki Takashina,&nbsp;Hyunsoo Chung,&nbsp;Yasuharu Maeda,&nbsp;Wai Phyo Lwin,&nbsp;Yosuke Toya,&nbsp;Waku Hatta,&nbsp;Jimmy Bok Yan So,&nbsp;Khay Guan Yeoh,&nbsp;Tetsuo Nemoto,&nbsp;Masashi Misawa","doi":"10.1111/den.70042","DOIUrl":"10.1111/den.70042","url":null,"abstract":"<div>\u0000 \u0000 <p>With the widespread use of advanced endoscopic techniques such as endoscopic submucosal dissection, an increasing number of early colorectal cancer (T1 CRC) and early gastric cancer (EGC) cases are now treated with endoscopic resection as the first-line approach. However, the risk of lymph node metastasis (LNM)—approximately 10% in T1 CRC and 5%–10% in EGC—necessitates additional surgical resection in high-risk cases. Current guideline-based risk stratification depends on pathological evaluation of the resected specimens to determine whether further surgery is needed. Yet both T1 CRC and EGC face shared challenges in LNM risk prediction, particularly in terms of accuracy and reproducibility. This review focuses on the latter. The diagnosis of key pathological risk factors, which serve as predictors of LNM, is subject to considerable interobserver variability among pathologists. One potential solution is the application of artificial intelligence (AI)-assisted whole slide image (WSI) analysis, which has been gaining attention in recent studies. AI-assisted models for LNM prediction in T1 CRC and EGC have shown encouraging results, suggesting that WSI-based AI could offer a pathologist-independent strategy to improve diagnostic consistency. However, the field remains in an early stage, with key limitations including small sample sizes and limited external validation. Additional high-quality evidence will be needed to support clinical implementation. Addressing challenges such as stain standardization and image artifacts will also be critical for achieving regulatory approval and broader clinical adoption.</p>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145180634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Ultrasound-Directed Transgastric ERCP in Patients With Roux-En-Y Gastric Bypass: A Multicenter Prospective Cohort Study (EDGE-Pilot) 内镜超声引导下经胃ERCP在Roux-En-Y胃旁路术患者中的应用:一项多中心前瞻性队列研究(EDGE-Pilot)。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-23 DOI: 10.1111/den.70037
A. G. Overdevest, S. Haal, J. E. van Hooft, A. Inderson, S. D. Kuiken, W. O. A. Rohof, J. M. Vrolijk, M. C. B. Wielenga, T. Wijnands, R. L. J. van Wanrooij, R. P. Voermans

Objectives

Endoscopic retrograde cholangiopancreatography (ERCP) is frequently indicated in patients who underwent Roux-en-Y gastric bypass (RYGB) surgery. Endoscopic ultrasound-directed ERCP (EDGE) is a technique that is used to create a gastro-gastrostomy by placing a lumen-apposing metal stent (LAMS) between the gastric pouch and the excluded stomach, facilitating subsequent ERCP. However, prospective studies on EDGE are lacking. The aim of this study is to provide prospective evidence for the efficacy and safety of EDGE, including fistula closure.

Methods

This multicenter prospective cohort study included patients scheduled for elective ERCP after RYGB surgery. EDGE was performed as a two-step procedure. The primary endpoint was overall technical success. Secondary endpoints were the technical success of LAMS placement and ERCP individually, persistent fistula, and adverse events (AEs).

Results

Between January 2021 and August 2024, 26 patients were included in four Dutch hospitals. Overall technical success was achieved in 25/26 patients (96.2%). Median LAMS indwelling time was 14 days [IQR 11–28 days]. Two EDGE-related AEs occurred (7.7%): one perforation of the duodenal wall following scope insertion and one bleeding after LAMS placement. Two ERCP-related AEs occurred (7.7%): one CBD perforation and one post-ERCP pancreatitis. Two patients were lost to follow-up. None of the remaining patients had a persistent fistula (0/24). No mortality occurred.

Conclusions

This prospective study shows that two-step EDGE is relatively safe and associated with high technical success, without any cases of a persistent fistula. However, AEs occurred in 4 patients (15.4%), of which two were EDGE-related (7.7%).

目的:内镜逆行胰胆管造影(ERCP)常用于Roux-en-Y胃旁路手术(RYGB)患者。内镜下超声定向ERCP (EDGE)是一种通过在胃袋和被排除的胃之间放置腔侧金属支架(LAMS)来创建胃-胃造口术的技术,便于后续的ERCP。然而,缺乏对EDGE的前瞻性研究。本研究的目的是为EDGE的有效性和安全性提供前瞻性证据,包括瘘管闭合。方法:这项多中心前瞻性队列研究纳入了RYGB手术后计划择期ERCP的患者。EDGE手术分为两步进行。主要终点是总体技术成功。次要终点是LAMS放置和ERCP单独的技术成功,持续瘘管和不良事件(ae)。结果:2021年1月至2024年8月,荷兰四家医院共纳入26例患者。26例患者中有25例(96.2%)取得了总体技术成功。LAMS中位留置时间为14天[IQR 11 ~ 28天]。发生2例与边缘相关的不良事件(7.7%):1例置入内镜后十二指肠壁穿孔,1例置入LAMS后出血。发生2例ercp相关不良事件(7.7%):1例CBD穿孔和1例ercp后胰腺炎。2例患者未随访。其余患者均无持续性瘘管(0/24)。无死亡发生。结论:这项前瞻性研究表明,两步EDGE相对安全,技术成功率高,没有任何持续瘘管的病例。然而,4例(15.4%)患者发生ae,其中2例与edge相关(7.7%)。
{"title":"Endoscopic Ultrasound-Directed Transgastric ERCP in Patients With Roux-En-Y Gastric Bypass: A Multicenter Prospective Cohort Study (EDGE-Pilot)","authors":"A. G. Overdevest,&nbsp;S. Haal,&nbsp;J. E. van Hooft,&nbsp;A. Inderson,&nbsp;S. D. Kuiken,&nbsp;W. O. A. Rohof,&nbsp;J. M. Vrolijk,&nbsp;M. C. B. Wielenga,&nbsp;T. Wijnands,&nbsp;R. L. J. van Wanrooij,&nbsp;R. P. Voermans","doi":"10.1111/den.70037","DOIUrl":"10.1111/den.70037","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Endoscopic retrograde cholangiopancreatography (ERCP) is frequently indicated in patients who underwent Roux-en-Y gastric bypass (RYGB) surgery. Endoscopic ultrasound-directed ERCP (EDGE) is a technique that is used to create a gastro-gastrostomy by placing a lumen-apposing metal stent (LAMS) between the gastric pouch and the excluded stomach, facilitating subsequent ERCP. However, prospective studies on EDGE are lacking. The aim of this study is to provide prospective evidence for the efficacy and safety of EDGE, including fistula closure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This multicenter prospective cohort study included patients scheduled for elective ERCP after RYGB surgery. EDGE was performed as a two-step procedure. The primary endpoint was overall technical success. Secondary endpoints were the technical success of LAMS placement and ERCP individually, persistent fistula, and adverse events (AEs).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Between January 2021 and August 2024, 26 patients were included in four Dutch hospitals. Overall technical success was achieved in 25/26 patients (96.2%). Median LAMS indwelling time was 14 days [IQR 11–28 days]. Two EDGE-related AEs occurred (7.7%): one perforation of the duodenal wall following scope insertion and one bleeding after LAMS placement. Two ERCP-related AEs occurred (7.7%): one CBD perforation and one post-ERCP pancreatitis. Two patients were lost to follow-up. None of the remaining patients had a persistent fistula (0/24). No mortality occurred.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This prospective study shows that two-step EDGE is relatively safe and associated with high technical success, without any cases of a persistent fistula. However, AEs occurred in 4 patients (15.4%), of which two were EDGE-related (7.7%).</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tribute to Our Reviewers 致敬我们的审稿人
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-22 DOI: 10.1111/den.70036
Masayuki Kitano
<p>It is our greatest pleasure to recognize the many individuals who have provided their valuable time and expertise to support <i>Digestive Endoscopy</i>. The editorial board wishes to acknowledge with particular gratitude the following Reviewers who have reviewed papers during the period of July 2024 to June 2025.</p><p>Hirofumi Abe</p><p>Hiroko Abe</p><p>Seiichiro Abe</p><p>Omer Ahmad</p><p>Yoichi Akazawa</p><p>Ahmed Altonbary</p><p>Andrea Anderloni</p><p>Katsuyoshi Ando</p><p>Livia Archibugi</p><p>Daisuke Asaoka</p><p>Reiko Ashida</p><p>Hiroshi Ashizawa</p><p>Ravishankar Asokkumar</p><p>Shigeki Bamba</p><p>Alexandre Bestetti</p><p>Purnima Bhat</p><p>Shannon Chan</p><p>Hideyuki Chiba</p><p>Daisuke Chinda</p><p>Akiko Chino</p><p>Joo Young Cho</p><p>Maria Cristina Conti Bellocchi</p><p>Stefano Francesco Crinò</p><p>Antoine Debourdeau</p><p>Pierre Deprez</p><p>Massimiliano di Pietro</p><p>Akira Dobashi</p><p>Osamu Dohi</p><p>Shinpei Doi</p><p>Shungo Endo</p><p>Mitsuru Esaki</p><p>Antonio Facciorusso</p><p>Wesam Frandah</p><p>Yuki Fujii</p><p>Nao Fujimori</p><p>Ai Fujimoto</p><p>Toshio Fujisawa</p><p>Koichi Fujita</p><p>Mitsuharu Fukasawa</p><p>Masahide Fukuda</p><p>Rintaro Fukuda</p><p>Sho Fukuda</p><p>Seiichiro Fukuhara</p><p>Shusei Fukunaga</p><p>Hiroto Furuhashi</p><p>Kuniyo Gomi</p><p>Samir Grover</p><p>Saurabh Gupta</p><p>Tae-Geun Gweon</p><p>Shin Haba</p><p>Ryunosuke Hakuta</p><p>Natalie Halvorsen</p><p>Koichi Hamada</p><p>Tsuyoshi Hamada</p><p>Hidetaka Hamamoto</p><p>Keiji Hanada</p><p>Kazuo Hara</p><p>Shinichi Hashimoto</p><p>Cesare Hassan</p><p>Waku Hatta</p><p>Shiro Hayashi</p><p>Yoshikazu Hayashi</p><p>Bu Hayee</p><p>Hisashi Hidaka</p><p>Susumu Hijioka</p><p>Takuto Hikichi</p><p>Makoto Hinokuchi</p><p>Toshiaki Hirasawa</p><p>Daizen Hirata</p><p>Takashi Hirose</p><p>Morihisa Hirota</p><p>Mariko Hojo</p><p>Keisuke Hori</p><p>Yasuki Hori</p><p>Akira Horiuchi</p><p>Yusuke Horiuchi</p><p>Naoki Hosoe</p><p>Shuhei Hosomi</p><p>Shu Hoteya</p><p>Kinichi Hotta</p><p>Wen-Feng Hsu</p><p>Bing Hu</p><p>Marietta Iacucci</p><p>Ryoji Ichijima</p><p>Katsuro Ichimasa</p><p>Daisuke Ide</p><p>Noboru Ideno</p><p>Eikichi Ihara</p><p>Toshiro Iizuka</p><p>Yuichiro Ikebuchi</p><p>Hisatomo Ikehara</p><p>Yohei Ikenoyama</p><p>Tsukasa Ikeura</p><p>Kenji Ikezawa</p><p>Atsushi Imagawa</p><p>Atsushi Inaba</p><p>Masahiko Inamori</p><p>Kazuya Inoki</p><p>Ken Inoue</p><p>Tadahisa Inoue</p><p>Fumiaki Ishibashi</p><p>Natsuki Ishida</p><p>Yusuke Ishida</p><p>Kazunaga Ishigaki</p><p>Naoki Ishii</p><p>Shigeto Ishii</p><p>Tatsuya Ishii</p><p>Yasutaka Ishii</p><p>Takuya Ishikawa</p><p>Tsuyoshi Ishikawa</p><p>Norihisa Ishimura</p><p>Mamoru Ito</p><p>Nobuhito Ito</p><p>Sayo Ito</p><p>Norio Itokawa</p><p>Masahiro Itonaga</p><p>Hiroyoshi Iwagami</p><p>Naoto Iwai</p><p>Keisuke Iwata</p><p>Mineo Iwatate</p><p>Yugo Iwaya</p><p>Seok Jeong</p><p>Tomohiro Kadota</p><p>Yoichi Kakuta</p><p>Rakesh Kalapala</p><p>Tomoari Kamada</p><p>Faisal Kamal</p><p>Ken Kamata</p><p>Shunsuke Kamba</p><p>
这是我们最大的荣幸认识到许多人谁提供了宝贵的时间和专业知识,以支持消化内窥镜。编委会特别感谢以下评审人员,他们在2024年7月至2025年6月期间对论文进行了评审。Hirofumi AbeHiroko AbeSeiichiro AbeOmer AhmadYoichi AkazawaAhmed AltonbaryAndrea AnderloniKatsuyoshi AndoLivia archibuichi hiroichi akazawaravishankar AsokkumarShigeki BambaAlexandre BestettiPurnima BhatShannon ChanHideyuki ChibaDaisuke ChindaAkiko ChinoJoo Young ChoMaria Cristina Conti BellocchiStefano Francesco CrinòAntoine DebourdeauPierre DeprezMassimiliano di pietroira dobashidohishinpei DoiShungo EndoMitsuru EsakiAntonio facciorussoveram FrandahYuki FujiiNao藤森爱,藤本敏夫,藤本久夫,藤本久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫,藤森久夫hirosemihhirohiroamariko, HojoKeisuke,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,堀江贵夫,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,池渊,井上,井渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊,石渊石康孝,石孝孝,石川孝孝,石川孝孝,石川孝孝,石川孝孝,石川孝孝,石川孝孝,石川孝孝,石川孝孝,石川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝,岩川孝孝木本孝明,木本孝明,木村孝孝,木村孝孝,木村孝孝,北川孝也,北村孝孝,小林孝介,小林孝介,小林孝介,小山孝孝,久保孝,久保孝,久保孝,久保孝,久保孝,久昌一,广尚洙,李孟英,林恩英,林恩英,久保孝,久保孝,久保孝,久保孝,久保孝,久保孝丸田弘夫丸山孝彦丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,丸山孝彦,nadatanikazasa长井康明,长井佑子,长崎和典,长岛康明,中村康明,中村康明,中村康明,中村康明,中村康明,中村康明,中村康明,西村康明,西川康明,西川康明,北村康明,野村康明,野村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明,小村康明OkunoNozomi OkunoKosuke OkuwakiMasaki ominamitpei OmoriShunsuke omoshoko OnoTakumi小山正二小谷正二小谷正二小谷正二小谷正二小谷正二小谷正二小谷正二小谷正二小谷正二小谷正二小谷正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正二小本正三坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,坂崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎,杉崎孝太郎高桥和纪,高田和纪,高田和纪,高田和纪,高田广纪,高田广纪,高田广纪,高田广知,高田广知,taktakakento, TakenakaManabu, TakeuchiKohei, takizawa, uzuru, TamaruTakashi,田村,田村,谷文雄,田中昭德 这是我们最大的荣幸认识到许多人谁提供了宝贵的时间和专业知识,以支持消化内窥镜。编委会特别感谢以下评审人员,他们在2024年7月至2025年6月期间对论文进行了评审。
{"title":"Tribute to Our Reviewers","authors":"Masayuki Kitano","doi":"10.1111/den.70036","DOIUrl":"https://doi.org/10.1111/den.70036","url":null,"abstract":"&lt;p&gt;It is our greatest pleasure to recognize the many individuals who have provided their valuable time and expertise to support &lt;i&gt;Digestive Endoscopy&lt;/i&gt;. The editorial board wishes to acknowledge with particular gratitude the following Reviewers who have reviewed papers during the period of July 2024 to June 2025.&lt;/p&gt;&lt;p&gt;Hirofumi Abe&lt;/p&gt;&lt;p&gt;Hiroko Abe&lt;/p&gt;&lt;p&gt;Seiichiro Abe&lt;/p&gt;&lt;p&gt;Omer Ahmad&lt;/p&gt;&lt;p&gt;Yoichi Akazawa&lt;/p&gt;&lt;p&gt;Ahmed Altonbary&lt;/p&gt;&lt;p&gt;Andrea Anderloni&lt;/p&gt;&lt;p&gt;Katsuyoshi Ando&lt;/p&gt;&lt;p&gt;Livia Archibugi&lt;/p&gt;&lt;p&gt;Daisuke Asaoka&lt;/p&gt;&lt;p&gt;Reiko Ashida&lt;/p&gt;&lt;p&gt;Hiroshi Ashizawa&lt;/p&gt;&lt;p&gt;Ravishankar Asokkumar&lt;/p&gt;&lt;p&gt;Shigeki Bamba&lt;/p&gt;&lt;p&gt;Alexandre Bestetti&lt;/p&gt;&lt;p&gt;Purnima Bhat&lt;/p&gt;&lt;p&gt;Shannon Chan&lt;/p&gt;&lt;p&gt;Hideyuki Chiba&lt;/p&gt;&lt;p&gt;Daisuke Chinda&lt;/p&gt;&lt;p&gt;Akiko Chino&lt;/p&gt;&lt;p&gt;Joo Young Cho&lt;/p&gt;&lt;p&gt;Maria Cristina Conti Bellocchi&lt;/p&gt;&lt;p&gt;Stefano Francesco Crinò&lt;/p&gt;&lt;p&gt;Antoine Debourdeau&lt;/p&gt;&lt;p&gt;Pierre Deprez&lt;/p&gt;&lt;p&gt;Massimiliano di Pietro&lt;/p&gt;&lt;p&gt;Akira Dobashi&lt;/p&gt;&lt;p&gt;Osamu Dohi&lt;/p&gt;&lt;p&gt;Shinpei Doi&lt;/p&gt;&lt;p&gt;Shungo Endo&lt;/p&gt;&lt;p&gt;Mitsuru Esaki&lt;/p&gt;&lt;p&gt;Antonio Facciorusso&lt;/p&gt;&lt;p&gt;Wesam Frandah&lt;/p&gt;&lt;p&gt;Yuki Fujii&lt;/p&gt;&lt;p&gt;Nao Fujimori&lt;/p&gt;&lt;p&gt;Ai Fujimoto&lt;/p&gt;&lt;p&gt;Toshio Fujisawa&lt;/p&gt;&lt;p&gt;Koichi Fujita&lt;/p&gt;&lt;p&gt;Mitsuharu Fukasawa&lt;/p&gt;&lt;p&gt;Masahide Fukuda&lt;/p&gt;&lt;p&gt;Rintaro Fukuda&lt;/p&gt;&lt;p&gt;Sho Fukuda&lt;/p&gt;&lt;p&gt;Seiichiro Fukuhara&lt;/p&gt;&lt;p&gt;Shusei Fukunaga&lt;/p&gt;&lt;p&gt;Hiroto Furuhashi&lt;/p&gt;&lt;p&gt;Kuniyo Gomi&lt;/p&gt;&lt;p&gt;Samir Grover&lt;/p&gt;&lt;p&gt;Saurabh Gupta&lt;/p&gt;&lt;p&gt;Tae-Geun Gweon&lt;/p&gt;&lt;p&gt;Shin Haba&lt;/p&gt;&lt;p&gt;Ryunosuke Hakuta&lt;/p&gt;&lt;p&gt;Natalie Halvorsen&lt;/p&gt;&lt;p&gt;Koichi Hamada&lt;/p&gt;&lt;p&gt;Tsuyoshi Hamada&lt;/p&gt;&lt;p&gt;Hidetaka Hamamoto&lt;/p&gt;&lt;p&gt;Keiji Hanada&lt;/p&gt;&lt;p&gt;Kazuo Hara&lt;/p&gt;&lt;p&gt;Shinichi Hashimoto&lt;/p&gt;&lt;p&gt;Cesare Hassan&lt;/p&gt;&lt;p&gt;Waku Hatta&lt;/p&gt;&lt;p&gt;Shiro Hayashi&lt;/p&gt;&lt;p&gt;Yoshikazu Hayashi&lt;/p&gt;&lt;p&gt;Bu Hayee&lt;/p&gt;&lt;p&gt;Hisashi Hidaka&lt;/p&gt;&lt;p&gt;Susumu Hijioka&lt;/p&gt;&lt;p&gt;Takuto Hikichi&lt;/p&gt;&lt;p&gt;Makoto Hinokuchi&lt;/p&gt;&lt;p&gt;Toshiaki Hirasawa&lt;/p&gt;&lt;p&gt;Daizen Hirata&lt;/p&gt;&lt;p&gt;Takashi Hirose&lt;/p&gt;&lt;p&gt;Morihisa Hirota&lt;/p&gt;&lt;p&gt;Mariko Hojo&lt;/p&gt;&lt;p&gt;Keisuke Hori&lt;/p&gt;&lt;p&gt;Yasuki Hori&lt;/p&gt;&lt;p&gt;Akira Horiuchi&lt;/p&gt;&lt;p&gt;Yusuke Horiuchi&lt;/p&gt;&lt;p&gt;Naoki Hosoe&lt;/p&gt;&lt;p&gt;Shuhei Hosomi&lt;/p&gt;&lt;p&gt;Shu Hoteya&lt;/p&gt;&lt;p&gt;Kinichi Hotta&lt;/p&gt;&lt;p&gt;Wen-Feng Hsu&lt;/p&gt;&lt;p&gt;Bing Hu&lt;/p&gt;&lt;p&gt;Marietta Iacucci&lt;/p&gt;&lt;p&gt;Ryoji Ichijima&lt;/p&gt;&lt;p&gt;Katsuro Ichimasa&lt;/p&gt;&lt;p&gt;Daisuke Ide&lt;/p&gt;&lt;p&gt;Noboru Ideno&lt;/p&gt;&lt;p&gt;Eikichi Ihara&lt;/p&gt;&lt;p&gt;Toshiro Iizuka&lt;/p&gt;&lt;p&gt;Yuichiro Ikebuchi&lt;/p&gt;&lt;p&gt;Hisatomo Ikehara&lt;/p&gt;&lt;p&gt;Yohei Ikenoyama&lt;/p&gt;&lt;p&gt;Tsukasa Ikeura&lt;/p&gt;&lt;p&gt;Kenji Ikezawa&lt;/p&gt;&lt;p&gt;Atsushi Imagawa&lt;/p&gt;&lt;p&gt;Atsushi Inaba&lt;/p&gt;&lt;p&gt;Masahiko Inamori&lt;/p&gt;&lt;p&gt;Kazuya Inoki&lt;/p&gt;&lt;p&gt;Ken Inoue&lt;/p&gt;&lt;p&gt;Tadahisa Inoue&lt;/p&gt;&lt;p&gt;Fumiaki Ishibashi&lt;/p&gt;&lt;p&gt;Natsuki Ishida&lt;/p&gt;&lt;p&gt;Yusuke Ishida&lt;/p&gt;&lt;p&gt;Kazunaga Ishigaki&lt;/p&gt;&lt;p&gt;Naoki Ishii&lt;/p&gt;&lt;p&gt;Shigeto Ishii&lt;/p&gt;&lt;p&gt;Tatsuya Ishii&lt;/p&gt;&lt;p&gt;Yasutaka Ishii&lt;/p&gt;&lt;p&gt;Takuya Ishikawa&lt;/p&gt;&lt;p&gt;Tsuyoshi Ishikawa&lt;/p&gt;&lt;p&gt;Norihisa Ishimura&lt;/p&gt;&lt;p&gt;Mamoru Ito&lt;/p&gt;&lt;p&gt;Nobuhito Ito&lt;/p&gt;&lt;p&gt;Sayo Ito&lt;/p&gt;&lt;p&gt;Norio Itokawa&lt;/p&gt;&lt;p&gt;Masahiro Itonaga&lt;/p&gt;&lt;p&gt;Hiroyoshi Iwagami&lt;/p&gt;&lt;p&gt;Naoto Iwai&lt;/p&gt;&lt;p&gt;Keisuke Iwata&lt;/p&gt;&lt;p&gt;Mineo Iwatate&lt;/p&gt;&lt;p&gt;Yugo Iwaya&lt;/p&gt;&lt;p&gt;Seok Jeong&lt;/p&gt;&lt;p&gt;Tomohiro Kadota&lt;/p&gt;&lt;p&gt;Yoichi Kakuta&lt;/p&gt;&lt;p&gt;Rakesh Kalapala&lt;/p&gt;&lt;p&gt;Tomoari Kamada&lt;/p&gt;&lt;p&gt;Faisal Kamal&lt;/p&gt;&lt;p&gt;Ken Kamata&lt;/p&gt;&lt;p&gt;Shunsuke Kamba&lt;/p&gt;&lt;p&gt;","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 12","pages":"1379-1381"},"PeriodicalIF":4.7,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70036","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transvalvular Precision: Digital Cholangioscopy-Guided SEMS Deployment for Malignant Ileocecal Obstruction 经瓣精度:数字胆道镜引导下SEMS部署恶性回盲梗阻。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-18 DOI: 10.1111/den.70039
Shanbin Wu, Yan Zhang, Guoliang Zhao

Self-expanding metallic stents (SEMS) are a well-established treatment for acute malignant colonic obstructions, serving as palliative care for unresectable tumors or as a bridge to elective surgery, thereby avoiding emergency enterostomy [1]. While their efficacy in left-colon malignancies is well documented, their use in proximal colonic applications, particularly for ileocecal stenosis, remains underreported. The technical challenges of placing stents in the ileocecal region arise from anatomical complexities: the greater distance from the anus, the acute angulation at the ileocecal valve (ICV), and tumor-induced luminal distortion, all contributing to higher single-attempt failure rates [2, 3]. This report introduces a novel cholangioscopy-assisted technique that successfully achieved precise stent placement across the ICV in a patient with a malignant ileocecal tumor-induced intestinal obstruction (Video S1). A 61-year-old male presented with acute abdominal pain. CT imaging revealed an ileocecal tumor with suspected ileal intussusception, proximal small bowel dilation (Figure 1), and liver/lung metastases. Following multidisciplinary consultation, palliative SEMS placement was selected. Initial colonoscopy (CF-HQ290i, Olympus, Japan) demonstrated a circumferential, cauliflower-like tumor with complete ICV destruction and severe luminal stenosis. Conventional guidewire navigation using a bowie knife failed to traverse the tumor. The subsequent use of an ultra-slim cholangioscope (VedVision, Vedkang Medical, China; outer diameter 3.1 mm) allowed direct visualization and stricture traversal. After advancing the guidewire through the cholangioscope's working channel, a 10-cm uncovered SEMS was successfully deployed under dual endoscopic and fluoroscopic guidance. For cases where conventional stent placement is hindered by the ileocecal region's anatomical complexity or severe stenosis, the ultra-slim cholangioscope reliably traverses strictures under direct visualization. This method provides real-time intraluminal guidance for precise guidewire advancement and stent deployment, significantly enhancing procedural success rates and avoiding complications associated with blind manipulation. It broadens access to stent-based interventions, offering a viable bridging strategy for patients unsuitable for immediate or emergency surgery.

Shanbin Wu: original draft and video editing. Yan Zhang: review and editing. Guoliang Zhao: surgical operator and supervisory guidance.

The authors declare no conflicts of interest.

自膨胀金属支架(SEMS)是一种成熟的治疗急性恶性结肠梗阻的方法,可作为不可切除肿瘤的姑息治疗或作为选择性手术的桥梁,从而避免紧急肠造口。虽然其对左结肠恶性肿瘤的疗效已被充分证实,但其在结肠近端应用,特别是对回盲狭窄的应用,仍然报道不足。在回盲区放置支架的技术挑战来自解剖学的复杂性:离肛门的距离较远,回盲瓣(ICV)的急性成角,以及肿瘤诱导的管腔扭曲,所有这些都导致了更高的单次尝试失败率[2,3]。本报告介绍了一种新的胆道镜辅助技术,该技术成功地在恶性回盲区肿瘤诱导的肠梗阻患者的ICV上实现了精确的支架置入(视频S1)。一名61岁男性,表现为急性腹痛。CT显示回盲部肿瘤伴疑似回肠肠套叠,近端小肠扩张(图1),肝/肺转移。在多学科咨询后,选择姑息性SEMS安置。最初的结肠镜检查(CF-HQ290i, Olympus, Japan)显示为一环状花椰菜样肿瘤,ICV完全破坏,管腔严重狭窄。使用鲍伊刀的传统导丝导航无法穿过肿瘤。随后使用超薄胆管镜(VedVision, Vedkang Medical, China,外径3.1 mm),可以直接观察和穿越狭窄。将导丝推进至胆管镜工作通道后,在内镜和透视双重引导下成功部署了一个10cm的无盖SEMS。对于因回盲区解剖复杂性或严重狭窄而阻碍常规支架置入的病例,超薄胆管镜在直接可见下可靠地穿过狭窄。该方法为精确导丝推进和支架部署提供实时腔内引导,显著提高手术成功率,避免盲操作相关并发症。它拓宽了获得基于支架的干预措施的途径,为不适合立即或紧急手术的患者提供了可行的桥接策略。吴善斌:原稿、视频剪辑。张燕:审稿、编辑。赵国良:外科操作员和监督指导。作者声明无利益冲突。
{"title":"Transvalvular Precision: Digital Cholangioscopy-Guided SEMS Deployment for Malignant Ileocecal Obstruction","authors":"Shanbin Wu,&nbsp;Yan Zhang,&nbsp;Guoliang Zhao","doi":"10.1111/den.70039","DOIUrl":"10.1111/den.70039","url":null,"abstract":"<p>Self-expanding metallic stents (SEMS) are a well-established treatment for acute malignant colonic obstructions, serving as palliative care for unresectable tumors or as a bridge to elective surgery, thereby avoiding emergency enterostomy [<span>1</span>]. While their efficacy in left-colon malignancies is well documented, their use in proximal colonic applications, particularly for ileocecal stenosis, remains underreported. The technical challenges of placing stents in the ileocecal region arise from anatomical complexities: the greater distance from the anus, the acute angulation at the ileocecal valve (ICV), and tumor-induced luminal distortion, all contributing to higher single-attempt failure rates [<span>2, 3</span>]. This report introduces a novel cholangioscopy-assisted technique that successfully achieved precise stent placement across the ICV in a patient with a malignant ileocecal tumor-induced intestinal obstruction (Video S1). A 61-year-old male presented with acute abdominal pain. CT imaging revealed an ileocecal tumor with suspected ileal intussusception, proximal small bowel dilation (Figure 1), and liver/lung metastases. Following multidisciplinary consultation, palliative SEMS placement was selected. Initial colonoscopy (CF-HQ290i, Olympus, Japan) demonstrated a circumferential, cauliflower-like tumor with complete ICV destruction and severe luminal stenosis. Conventional guidewire navigation using a bowie knife failed to traverse the tumor. The subsequent use of an ultra-slim cholangioscope (VedVision, Vedkang Medical, China; outer diameter 3.1 mm) allowed direct visualization and stricture traversal. After advancing the guidewire through the cholangioscope's working channel, a 10-cm uncovered SEMS was successfully deployed under dual endoscopic and fluoroscopic guidance. For cases where conventional stent placement is hindered by the ileocecal region's anatomical complexity or severe stenosis, the ultra-slim cholangioscope reliably traverses strictures under direct visualization. This method provides real-time intraluminal guidance for precise guidewire advancement and stent deployment, significantly enhancing procedural success rates and avoiding complications associated with blind manipulation. It broadens access to stent-based interventions, offering a viable bridging strategy for patients unsuitable for immediate or emergency surgery.</p><p>Shanbin Wu: original draft and video editing. Yan Zhang: review and editing. Guoliang Zhao: surgical operator and supervisory guidance.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Artificial Intelligence, Including Endoscopic Diagnosis, in the Prediction of Presence, Bleeding, and Mortality of Esophageal Varices 人工智能的作用,包括内镜诊断,在预测存在,出血和死亡率的食管静脉曲张。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-18 DOI: 10.1111/den.70032
Yoshihiro Furuichi, Ryohei Nishiguchi, Yuko Furuichi, Shirei Kobayashi, Tomoyuki Fujiwara, Koichiro Sato

Esophagogastric varices (EGVs) are a disease that occurs as a complication of the progression of liver cirrhosis, and since bleeding can be fatal, regular endoscopy is necessary. With the development of artificial intelligence (AI) in recent years, it is beginning to be applied to predicting the presence of EGVs, predicting bleeding, and making a diagnosis and prognosis. Based on previous reports, application methods of AI can be classified into the following four categories: (1) noninvasive prediction using clinical data obtained from clinical records such as laboratory data, past history, and present illness, (2) invasive detection and prediction using endoscopy and computed tomography (CT), (3) invasive prediction using multimodal AI (clinical data and endoscopy), (4) invasive virtual measurement on the image of endoscopy and CT. These methods currently allow for the use of AI in the following ways: (1) prediction of EGVs existence, variceal grade, bleeding risk, and survival rate, (2) detection and diagnosis of esophageal varices (EVs), (3) prediction of bleeding within 1 year, (4) prediction of variceal diameter and portal pressure gradient. This review explores current studies on AI applications in assessing EGVs, highlighting their benefits, limitations, and future directions.

食管胃静脉曲张(EGVs)是肝硬化进展的一种并发症,由于出血可能是致命的,因此有必要定期进行内窥镜检查。近年来随着人工智能(AI)的发展,人工智能开始应用于预测egv的存在、预测出血、诊断和预后。根据以往的报道,人工智能的应用方法可分为以下四类:(1)利用临床记录(如实验室数据、既往病史和当前疾病)获得的临床数据进行无创预测;(2)利用内窥镜和计算机断层扫描(CT)进行有创检测和预测;(3)利用多模态人工智能(临床数据和内窥镜)进行有创预测;这些方法目前允许在以下方面使用AI:(1)预测egv的存在、静脉曲张等级、出血风险和生存率;(2)食管静脉曲张(ev)的检测和诊断;(3)预测1年内出血;(4)预测静脉曲张直径和门静脉压力梯度。本文综述了目前人工智能在egv评估中的应用研究,强调了它们的优点、局限性和未来发展方向。
{"title":"The Role of Artificial Intelligence, Including Endoscopic Diagnosis, in the Prediction of Presence, Bleeding, and Mortality of Esophageal Varices","authors":"Yoshihiro Furuichi,&nbsp;Ryohei Nishiguchi,&nbsp;Yuko Furuichi,&nbsp;Shirei Kobayashi,&nbsp;Tomoyuki Fujiwara,&nbsp;Koichiro Sato","doi":"10.1111/den.70032","DOIUrl":"10.1111/den.70032","url":null,"abstract":"<p>Esophagogastric varices (EGVs) are a disease that occurs as a complication of the progression of liver cirrhosis, and since bleeding can be fatal, regular endoscopy is necessary. With the development of artificial intelligence (AI) in recent years, it is beginning to be applied to predicting the presence of EGVs, predicting bleeding, and making a diagnosis and prognosis. Based on previous reports, application methods of AI can be classified into the following four categories: (1) noninvasive prediction using clinical data obtained from clinical records such as laboratory data, past history, and present illness, (2) invasive detection and prediction using endoscopy and computed tomography (CT), (3) invasive prediction using multimodal AI (clinical data and endoscopy), (4) invasive virtual measurement on the image of endoscopy and CT. These methods currently allow for the use of AI in the following ways: (1) prediction of EGVs existence, variceal grade, bleeding risk, and survival rate, (2) detection and diagnosis of esophageal varices (EVs), (3) prediction of bleeding within 1 year, (4) prediction of variceal diameter and portal pressure gradient. This review explores current studies on AI applications in assessing EGVs, highlighting their benefits, limitations, and future directions.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 12","pages":"1261-1272"},"PeriodicalIF":4.7,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Depth of Breathing Matter in Gastroesophageal Reflux? Esophagogastric Junction Barrier Function Should Also Be Considered 呼吸深度对胃食管反流有影响吗?还应考虑食管胃交界屏障功能。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-17 DOI: 10.1111/den.70038
Shiko Kuribayashi, Toshio Uraoka
<p>Gastroesophageal reflux disease (GERD) is defined as the presence of symptoms or complications related to the reflux of gastric contents into the esophagus. The diagnosis of GERD is primarily made by evaluating the symptoms in clinical practice. When the diagnosis of GERD is inconclusive, esophageal physiological evaluation can show evidence of the presence of GERD. The Lyon consensus provides conclusive criteria for and against the diagnosis of GERD, and the updated Lyon consensus shows that hiatal hernia evaluated by esophagogastroduodenoscopy (EGD) is considered supportive evidence for GERD [<span>1</span>].</p><p>The esophagogastric junction (EGJ) consists of the lower esophageal sphincter and the crural diaphragm, which prevent gastroesophageal reflux (GER). This antireflux barrier function of the EGJ has been assessed on EGD. Hill et al. showed that the appearance of a gastroesophageal flap valve (GEFV) was a better predictor of the presence or absence of GER than EGJ pressure [<span>2</span>]. Distending the stomach by air insufflation on EGD could simulate during the postprandial state in which GER is most likely to occur. Therefore, it is reasonable to evaluate the antireflux barrier function of the EGJ during gastric distention on EGD. Although a grading system for GEFV has been proposed, this system is a qualitative evaluation [<span>2</span>]. Thus, a quantitative evaluation of the antireflux barrier function of the EGJ on EGD is warranted.</p><p>An endoscopic pressure study integrated system (EPSIS) was developed. EPSIS can evaluate gastroesophageal barrier function quantitatively by measuring intragastric pressure and endoscopically observing the morphology of the EGJ simultaneously [<span>3</span>]. An increase in intragastric pressure by carbon dioxide (CO<sub>2</sub>) insufflation into the stomach is observed when the EGJ antireflux barrier function is preserved (uphill pattern). The intragastric pressure waveform does not show the uphill pattern because CO<sub>2</sub> evacuates from the stomach continuously when the EGJ barrier function is weakened (flat pattern). The flat pattern and low maximum intragastric pressure during CO<sub>2</sub> insufflation are associated with GERD. In addition, the pressure difference between the basal intragastric pressure and the maximum intragastric pressure during CO<sub>2</sub> insufflation and the pressure gradient of the waveform are also related to the acid exposure time (AET) [<span>4</span>]. Recently, it has been reported that EPSIS can assess the dynamics of antireflux barrier function as well as quantitative evaluation [<span>5</span>].</p><p>When intragastric pressure is measured during EPSIS, fluctuations in intragastric pressure are observed. Abiko et al. focused on the relationship between the magnitudes of fluctuations in the intragastric pressure during EPSIS and AET measured by esophageal impedance-pH monitoring and found that the magnitude of pressure fluctuation of the gastr
胃食管反流病(GERD)被定义为与胃内容物反流到食道相关的症状或并发症。在临床实践中,胃食管反流的诊断主要是通过对症状的评估来进行的。当胃食管反流的诊断不明确时,食管生理评估可以显示胃食管反流存在的证据。里昂共识为GERD的诊断提供了决定性的标准,更新的里昂共识显示,食管胃十二指肠镜(EGD)评估的裂孔疝被认为是GERD[1]的支持性证据。食管胃交界(EGJ)由下食管括约肌和脚膈组成,防止胃食管反流(GER)。EGJ的这种抗反流屏障功能已在EGD上进行了评估。Hill等人的研究表明,胃食管瓣瓣(GEFV)的出现比EGJ压力[2]更能预测是否存在GER。在EGD上充气扩张胃可以模拟最可能发生GER的餐后状态。因此,评价胃胀时EGJ的抗反流屏障功能对EGD的影响是合理的。虽然已经提出了GEFV的分级制度,但该制度是定性评价。因此,定量评价EGJ对EGD的抗反流屏障功能是有必要的。开发了一种内窥镜压力研究集成系统(EPSIS)。EPSIS可以定量评价胃食管屏障功能,通过测量胃内压和内镜下观察EGJ形态的同时[3]。当EGJ抗反流屏障功能保持时,观察到胃内二氧化碳(CO2)的增加(上坡模式)。胃内压波形不显示上坡模式,因为当EGJ屏障功能减弱时,CO2不断从胃中排出(平坦模式)。在二氧化碳充气过程中,平坦的模式和较低的最大胃内压与胃反流有关。此外,CO2充气时胃底压与最大胃内压的压差以及波形的压力梯度也与酸暴露时间(AET)[4]有关。最近,有报道称EPSIS可以评估抗反流屏障功能的动态变化以及定量评价[5]。在EPSIS期间测量胃内压时,可以观察到胃内压的波动。Abiko等人着重研究了EPSIS期间胃内压波动幅度与食管阻抗- ph监测测量的AET之间的关系,发现胃食管反流患者EPSIS期间胃压压力波动幅度可能与AET有关。胃内压的波动可由呼吸周期、血管搏动、伪影等引起。根据研究中评估的波动周期,它们一定是由呼吸周期产生的。吸气时胃内压升高,呼气结束时胃内压恢复到基线压力,产生胃内压波动。胃内压波高波动的幅度可能主要受呼吸深度和其他因素(如胃调节)的影响。重要的是,吸气时食管压降低,这反映了胸内压对抗胃内压的升高。吸气时经膈压力梯度(TPG)介于食管压力降低和胃内压力升高之间,被认为是胃食管反流(GER)的一个原因。由于EPSIS期间波形中高度波动的幅度反映了呼吸深度,因此Abiko等人的研究结果可以解释为与AET相关的TPG的幅度。TPG被认为是胃反流发病的重要因素,尤其是在睡眠研究中。当阻塞性睡眠呼吸暂停(OSA)事件发生时,食道负压和胃正压的大小逐渐增加,这是由于OSA事件期间呼吸努力增加引起的。由于OSA患者的GERD患病率很高,因此一直认为TPG强度的增加会诱发GER事件。此外,持续气道正压可减少OSA患者的GER事件,这支持了TPG升高可诱发GER的观点。然而,该理论并未考虑EGJ的势垒功能。 我们在OSA患者夜间同时进行了高分辨率食管测压、食管阻抗- ph监测和多导睡眠图,发现EGJ在TPG[8]增加的情况下可以预防GER事件。此外,没有任何OSA事件在阻抗或pH记录上有GER的证据。因此,在EGJ抗反流屏障功能保持不变的情况下,通过增强呼吸努力而增加的TPG不太可能诱发GER。在我们的研究中,患有大裂孔疝(EGJ屏障功能受损)的患者未纳入bbb。在腹部紧张、咳嗽和呼吸力增加时,脚膈负责预防GER。因此,在大裂孔疝患者中,TPG增强是否会诱发GER尚不清楚。由于EPSIS可以评估EGJ屏障功能和波形波动幅度(反映EPSIS中呼吸深度),因此有可能明确TPG是否与GERD有关,特别是在EGJ屏障功能受损的患者中。此外,通过内镜抗反流治疗恢复EGJ屏障功能在这些患者中应该是有效的。此外,在选择适合内镜下抗反流治疗的患者时,评估EGJ屏障功能和波形中波高波动的大小应该是有用的。食管测压和反流监测具有侵入性且耐受性较差,必须在餐后和睡眠状态同时进行,以确定TPG是否可诱导平卧位EGJ功能受损患者发生GER。为了同时评估EGJ屏障功能和呼吸深度,在EPSIS中同时评估EGJ屏障功能和波形波动幅度更容易且侵入性更小。肥胖、阻塞性睡眠呼吸暂停、呼吸系统疾病(如慢性阻塞性肺病)、心血管和神经肌肉疾病是已知影响患者TPG大小的危险因素。然而,该研究没有评估这些疾病的存在,尽管对体重指数进行了评估。此外,腹式呼吸的存在也可能是一个潜在因素。镇静的深度和内镜下气道阻塞的存在会影响TPG的大小。然而,没有评估EPSIS期间镇静的深度和气道阻塞的存在。应考虑这些因素,以规范胃内压波动幅度的评价方法。当胃中的气体被排出时(在胃打嗝时),食管上括约肌(UES)必须放松。虽然UES屏障功能在EPSIS扁平型患者中很重要,但在EPSIS中无法评估UES功能。医生应使用EPSIS评估胃食管反流患者的食管屏障功能。胃食管反流的病理生理涉及几个因素。虽然EGJ的屏障功能对GER的发生很重要,但短暂性食管下括约肌舒张(TLESR)是GER的主要机制。此外,低LES压力,吞咽相关的LES松弛和低LES压力期间的应变被称为GER的其他机制。胃食管清除率、唾液分泌能力、酸袋、胃萎缩等因素均可影响AET值。此外,食管感觉也是胃食管反流病理生理的重要因素。应对这些因素进行评估,以控制胃反流。综上所述,EPSIS期间波形的波高波动幅度可能有助于预测延长的AET,特别是在EGJ屏障功能受损的患者中。在进行EPSIS时,评估EGJ势垒函数和波形中的波高波动幅度是很重要的。负责起草手稿。T.U.负责监督稿件的准备工作。作者声明没有利益冲突。阿比子,岛村,井上,等。内窥镜压力研究集成系统波形中的波高波动有可能预测胃食管反流病中的酸反流(附视频)。https://doi.org/10.1111/den.15049
{"title":"Does Depth of Breathing Matter in Gastroesophageal Reflux? Esophagogastric Junction Barrier Function Should Also Be Considered","authors":"Shiko Kuribayashi,&nbsp;Toshio Uraoka","doi":"10.1111/den.70038","DOIUrl":"10.1111/den.70038","url":null,"abstract":"&lt;p&gt;Gastroesophageal reflux disease (GERD) is defined as the presence of symptoms or complications related to the reflux of gastric contents into the esophagus. The diagnosis of GERD is primarily made by evaluating the symptoms in clinical practice. When the diagnosis of GERD is inconclusive, esophageal physiological evaluation can show evidence of the presence of GERD. The Lyon consensus provides conclusive criteria for and against the diagnosis of GERD, and the updated Lyon consensus shows that hiatal hernia evaluated by esophagogastroduodenoscopy (EGD) is considered supportive evidence for GERD [&lt;span&gt;1&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;The esophagogastric junction (EGJ) consists of the lower esophageal sphincter and the crural diaphragm, which prevent gastroesophageal reflux (GER). This antireflux barrier function of the EGJ has been assessed on EGD. Hill et al. showed that the appearance of a gastroesophageal flap valve (GEFV) was a better predictor of the presence or absence of GER than EGJ pressure [&lt;span&gt;2&lt;/span&gt;]. Distending the stomach by air insufflation on EGD could simulate during the postprandial state in which GER is most likely to occur. Therefore, it is reasonable to evaluate the antireflux barrier function of the EGJ during gastric distention on EGD. Although a grading system for GEFV has been proposed, this system is a qualitative evaluation [&lt;span&gt;2&lt;/span&gt;]. Thus, a quantitative evaluation of the antireflux barrier function of the EGJ on EGD is warranted.&lt;/p&gt;&lt;p&gt;An endoscopic pressure study integrated system (EPSIS) was developed. EPSIS can evaluate gastroesophageal barrier function quantitatively by measuring intragastric pressure and endoscopically observing the morphology of the EGJ simultaneously [&lt;span&gt;3&lt;/span&gt;]. An increase in intragastric pressure by carbon dioxide (CO&lt;sub&gt;2&lt;/sub&gt;) insufflation into the stomach is observed when the EGJ antireflux barrier function is preserved (uphill pattern). The intragastric pressure waveform does not show the uphill pattern because CO&lt;sub&gt;2&lt;/sub&gt; evacuates from the stomach continuously when the EGJ barrier function is weakened (flat pattern). The flat pattern and low maximum intragastric pressure during CO&lt;sub&gt;2&lt;/sub&gt; insufflation are associated with GERD. In addition, the pressure difference between the basal intragastric pressure and the maximum intragastric pressure during CO&lt;sub&gt;2&lt;/sub&gt; insufflation and the pressure gradient of the waveform are also related to the acid exposure time (AET) [&lt;span&gt;4&lt;/span&gt;]. Recently, it has been reported that EPSIS can assess the dynamics of antireflux barrier function as well as quantitative evaluation [&lt;span&gt;5&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;When intragastric pressure is measured during EPSIS, fluctuations in intragastric pressure are observed. Abiko et al. focused on the relationship between the magnitudes of fluctuations in the intragastric pressure during EPSIS and AET measured by esophageal impedance-pH monitoring and found that the magnitude of pressure fluctuation of the gastr","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suprapapillary Stent-By-Stent Deployment With Slim-Fully Covered Versus Uncovered Metal Stents for Malignant Hilar Biliary Obstruction: A Multicenter Comparative Study (With Video) 小覆盖金属支架与未覆盖金属支架在恶性肝门胆道梗阻中的应用:多中心对比研究(附视频)。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-16 DOI: 10.1111/den.70031
Tadahisa Inoue, Michihiro Yoshida, Naoaki Yamada, Rena Kitano, Tomoya Kitada, Shun Futagami, Kenta Kachi, Fumihiro Okumura, Itaru Naitoh

Background

Bilateral uncovered metal stent (UMS) placement is recommended for unresectable malignant hilar biliary obstructions (MHBO). However, recent improvements in antitumor therapies and patient survival have led to an increasing number of patients outliving UMS patency, necessitating more frequent reinterventions. This study evaluated the efficacy of novel suprapapillary stent-by-stent (SBS) placement using slim fully covered metal stents (FCMS) and compared them with UMS.

Methods

A total of 254 patients were included. Technical and clinical success, adverse events (AEs) including recurrent biliary obstruction (RBO), and reintervention were compared between the FCMS and UMS groups. Propensity score matching was performed to adjust for between-group differences.

Results

Technical and clinical success rates and early and late AE rates were not significantly different between the groups. The FCMS group demonstrated a significantly lower RBO incidence rate (32.0% vs. 60.8%; p = 0.005) and a significantly longer time to RBO (median, NA vs. 204 days; p = 0.048). However, in the FCMS group, 4.0% of patients required stent removal because of suspected branch occlusion. The technical success rates of reintervention were 100% and 83.3% in the FCMS and UMS groups (p = 0.147), respectively. Compared to the UMS group, the FCMS group demonstrated a significantly shorter reintervention procedure time (median, 20 vs. 31 min; p = 0.005) and a significantly lower number of reinterventions (p = 0.029) and requirement for repeat reinterventions (p = 0.003).

Conclusions

Suprapapillary slim FCMS SBS placement may be a promising treatment option for patients with unresectable MHBO. However, early and unique events requiring stent removal should be carefully considered.

背景:双侧无盖金属支架(UMS)是不可切除的恶性肝门胆道梗阻(MHBO)的推荐植入术。然而,最近抗肿瘤治疗和患者生存的改善导致越来越多的患者超过了UMS通畅,需要更频繁的再干预。本研究评估了新型冠状动脉支架-支架(SBS)置入的效果,并将其与全覆盖金属支架(FCMS)进行比较。方法:共纳入254例患者。比较FCMS组和UMS组的技术和临床成功、不良事件(ae)(包括复发性胆道梗阻(RBO))和再干预。进行倾向评分匹配以调整组间差异。结果:两组间技术成功率、临床成功率及早期、晚期AE发生率无显著性差异。FCMS组RBO发生率显著降低(32.0% vs. 60.8%, p = 0.005), RBO发生时间显著延长(中位NA vs. 204天,p = 0.048)。然而,在FCMS组中,4.0%的患者因怀疑分支闭塞而需要移除支架。FCMS组和UMS组再干预技术成功率分别为100%和83.3% (p = 0.147)。与UMS组相比,FCMS组的再干预时间显著缩短(中位数20分钟vs. 31分钟;p = 0.005),再干预次数显著减少(p = 0.029),重复再干预的需求显著减少(p = 0.003)。结论:对于无法切除的MHBO患者,在乳头上放置纤细的FCMS SBS可能是一种很有希望的治疗选择。然而,需要移除支架的早期和特殊事件应仔细考虑。
{"title":"Suprapapillary Stent-By-Stent Deployment With Slim-Fully Covered Versus Uncovered Metal Stents for Malignant Hilar Biliary Obstruction: A Multicenter Comparative Study (With Video)","authors":"Tadahisa Inoue,&nbsp;Michihiro Yoshida,&nbsp;Naoaki Yamada,&nbsp;Rena Kitano,&nbsp;Tomoya Kitada,&nbsp;Shun Futagami,&nbsp;Kenta Kachi,&nbsp;Fumihiro Okumura,&nbsp;Itaru Naitoh","doi":"10.1111/den.70031","DOIUrl":"10.1111/den.70031","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Bilateral uncovered metal stent (UMS) placement is recommended for unresectable malignant hilar biliary obstructions (MHBO). However, recent improvements in antitumor therapies and patient survival have led to an increasing number of patients outliving UMS patency, necessitating more frequent reinterventions. This study evaluated the efficacy of novel suprapapillary stent-by-stent (SBS) placement using slim fully covered metal stents (FCMS) and compared them with UMS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 254 patients were included. Technical and clinical success, adverse events (AEs) including recurrent biliary obstruction (RBO), and reintervention were compared between the FCMS and UMS groups. Propensity score matching was performed to adjust for between-group differences.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Technical and clinical success rates and early and late AE rates were not significantly different between the groups. The FCMS group demonstrated a significantly lower RBO incidence rate (32.0% vs. 60.8%; <i>p</i> = 0.005) and a significantly longer time to RBO (median, NA vs. 204 days; <i>p</i> = 0.048). However, in the FCMS group, 4.0% of patients required stent removal because of suspected branch occlusion. The technical success rates of reintervention were 100% and 83.3% in the FCMS and UMS groups (<i>p</i> = 0.147), respectively. Compared to the UMS group, the FCMS group demonstrated a significantly shorter reintervention procedure time (median, 20 vs. 31 min; <i>p</i> = 0.005) and a significantly lower number of reinterventions (<i>p</i> = 0.029) and requirement for repeat reinterventions (<i>p</i> = 0.003).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Suprapapillary slim FCMS SBS placement may be a promising treatment option for patients with unresectable MHBO. However, early and unique events requiring stent removal should be carefully considered.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 12","pages":"1295-1305"},"PeriodicalIF":4.7,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Saline-Immersion Endoscopic Hemostasis With Flow-Assisted Coagulation Using Gas-Free Immersion System 新型无气体浸入式内镜下盐浸式血流辅助止血系统。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-14 DOI: 10.1111/den.70035
Tatsuma Nomura, Katsumi Mukai

Recently, various endoscopic techniques performed under saline immersion have been reported. However, in such settings, mixing of blood and water results in poor endoscopic visibility, making it difficult to identify the appropriate hemostatic point [1]. To address this, we developed a gas-free immersion (GFI) system that employs a hood with a 4-mm tapered tip and saline to generate turbulence within the hood [2, 3]. This turbulence is produced by pressing the air/water valve button, allowing the endoscopic view to be maintained without using CO2. Recently, the flushing forced method was reported as a useful precoagulation technique because in saline floating environments, arc formation and spark are suppressed because the electrical current scattered into the surrounding field [4]. We report flow-assisted coagulation using GFI (GFI-FAC), which facilitates hemostasis under saline by applying flow within the narrow hood using the water valve button.

The patient had a 35-mm type 0-I tumor with fibrosis in the cecum (Figure 1, Video S1). We performed an en bloc ESD using GFI-FAC. First, a mucosal incision was made on the anal side. The submucosa was dissected, and the blood vessels were precoagulated by allowing saline to flow around the knife blade while pressing the water valve button in coagulation mode (VIO300D: Forced E4-50W, VIO3: Forced E3.5–4.0), without causing sparking. If active hemorrhage occurred, hemostasis was achieved by coagulating while confirming the hemostatic point with saline irrigated in the hood. Dissection of the submucosa and fibrosis was performed using the cutting mode, and the tumor was safely removed. The pathological diagnosis was intramucosal carcinoma, and the tumor was completely resected. Defect closure was achieved using the reopenable-clip over the line method, and the patient was discharged without adverse events [5]. GFI-FAC can be used for achieving safe hemostasis under saline-immersion conditions by creating turbulence in the hood.

Tatsuma Nomura made substantial contributions to the conceptualization of the study. Katsumi Mukai contributed substantially to the revision of the manuscript.

The authors declare no conflicts of interest.

最近,各种内镜技术在盐水浸泡下进行了报道。然而,在这种情况下,血液和水的混合导致内窥镜能见度低,难以确定合适的止血点[1]。为了解决这个问题,我们开发了一种无气体浸泡(GFI)系统,该系统采用了一个4毫米锥形尖端的发动机罩和盐水来产生发动机罩内的湍流[2,3]。这种湍流是通过按空气/水阀按钮产生的,可以在不使用二氧化碳的情况下保持内窥镜视野。最近,强制冲洗法被报道为一种有用的预凝技术,因为在盐水漂浮环境中,由于电流散射到周围的场[4],电弧和火花被抑制。我们报告使用GFI (GFI- fac)进行血流辅助凝血,它通过使用水阀按钮在狭窄的罩内施加血流来促进生理盐水下的止血。患者为盲肠纤维化的35毫米0-I型肿瘤(图1,视频S1)。我们使用GFI-FAC进行了整体ESD。首先,在肛门侧做一个粘膜切口。切开粘膜下层,在凝固模式(VIO300D:强制E4-50W, VIO3:强制E3.5-4.0)下按水阀按钮,让生理盐水在刀片周围流动,对血管进行预凝固,不产生火花。如发生活动性出血,则在确定止血点的同时,用生理盐水在头罩内冲洗止血。采用切割方式对粘膜下层及纤维化进行剥离,安全切除肿瘤。病理诊断为粘膜内癌,并完全切除肿瘤。使用可重新打开的夹线方法完成缺损闭合,患者出院时无不良事件[5]。GFI-FAC可用于在盐水浸泡条件下通过在罩内产生湍流来实现安全止血。Tatsuma Nomura对该研究的概念化做出了重大贡献。Katsumi Mukai对手稿的修订做出了重大贡献。作者声明无利益冲突。
{"title":"Novel Saline-Immersion Endoscopic Hemostasis With Flow-Assisted Coagulation Using Gas-Free Immersion System","authors":"Tatsuma Nomura,&nbsp;Katsumi Mukai","doi":"10.1111/den.70035","DOIUrl":"10.1111/den.70035","url":null,"abstract":"<p>Recently, various endoscopic techniques performed under saline immersion have been reported. However, in such settings, mixing of blood and water results in poor endoscopic visibility, making it difficult to identify the appropriate hemostatic point [<span>1</span>]. To address this, we developed a gas-free immersion (GFI) system that employs a hood with a 4-mm tapered tip and saline to generate turbulence within the hood [<span>2, 3</span>]. This turbulence is produced by pressing the air/water valve button, allowing the endoscopic view to be maintained without using CO<sub>2</sub>. Recently, the flushing forced method was reported as a useful precoagulation technique because in saline floating environments, arc formation and spark are suppressed because the electrical current scattered into the surrounding field [<span>4</span>]. We report flow-assisted coagulation using GFI (GFI-FAC), which facilitates hemostasis under saline by applying flow within the narrow hood using the water valve button.</p><p>The patient had a 35-mm type 0-I tumor with fibrosis in the cecum (Figure 1, Video S1). We performed an en bloc ESD using GFI-FAC. First, a mucosal incision was made on the anal side. The submucosa was dissected, and the blood vessels were precoagulated by allowing saline to flow around the knife blade while pressing the water valve button in coagulation mode (VIO300D: Forced E4-50W, VIO3: Forced E3.5–4.0), without causing sparking. If active hemorrhage occurred, hemostasis was achieved by coagulating while confirming the hemostatic point with saline irrigated in the hood. Dissection of the submucosa and fibrosis was performed using the cutting mode, and the tumor was safely removed. The pathological diagnosis was intramucosal carcinoma, and the tumor was completely resected. Defect closure was achieved using the reopenable-clip over the line method, and the patient was discharged without adverse events [<span>5</span>]. GFI-FAC can be used for achieving safe hemostasis under saline-immersion conditions by creating turbulence in the hood.</p><p>Tatsuma Nomura made substantial contributions to the conceptualization of the study. Katsumi Mukai contributed substantially to the revision of the manuscript.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Multicenter Pivotal Study on the Artificial Intelligence System for Neoplastic Lesions Detection in Upper Gastrointestinal Endoscopy 上消化道内镜下肿瘤病变人工智能检测系统的多中心枢纽研究。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-12 DOI: 10.1111/den.70015
Seiichiro Abe, Yoshiyasu Kitagawa, Waku Hatta, Takao Maekita, Motohiko Kato, Akihito Nagahara, Hiroyuki Osawa, Osamu Dohi, Hirotaka Nakashima, Kazuhiro Furukawa, Shiro Oka, Tomoko Yokoyama, Toru Ito, Ichiro Oda

Objectives

This pivotal study aimed to evaluate the performance of the CAD-EYE prototype in identifying esophageal squamous cell carcinoma (ESCC) and gastric neoplasm (GN) for regulatory approval of the Pharmaceuticals and Medical Devices Agency in Japan.

Methods

This retrospective study utilized image datasets comprising 15 consecutive video frames captured using non-magnifying white-light imaging (WLI), blue laser/light imaging (BLI), and linked color imaging (LCI). The sensitivity and specificity of the CAD-EYE prototype for successful detection were calculated using the gold standard, which consists of image datasets of neoplastic lesions annotated by experienced endoscopists.

Results

A total of 620, 679, and 682 ESCC datasets were analyzed in the WLI, BLI, and LCI groups, respectively. The sensitivity and specificity of ESCC detection were 85.9% [81.1%–90.6%] and 93.3% [90.8%–95.7%] in the WLI group, 97.6% [95.6%–99.7%] and 92.9% [90.6%–95.3%] in the BLI group, and 96.6% [94.2%–99.1%] and 93.2% [91.0%–95.5%] in the LCI group. The sensitivities for pT1a ESCC were 85.3%, 97.3%, and 97.2% in the WLI, BLI, and LCI groups, respectively. For GN, 841 WLI and 882 LCI datasets were analyzed. The sensitivity, specificity, and specificity in the detection flag of GN detection were 95.5% [92.8%–98.1%], 86.1%, and 85.4% [82.6%–88.2%] in the WLI group, and 93.9% [91.1%–96.7%], 94.4%, and 93.9% [92.0%–95.8%] in the LCI group, respectively. The sensitivities for pT1a early gastric cancer were 93.8% and 92.4% in the WLI and LCI groups, respectively.

Conclusions

The CAD-EYE prototype demonstrated high sensitivity in detecting ESCC and GN, highlighting its potential as a promising tool for clinical applications.

目的:本关键研究旨在评估CAD-EYE原型在识别食管鳞状细胞癌(ESCC)和胃肿瘤(GN)方面的性能,以获得日本药品和医疗器械管理局的监管批准。方法:本回顾性研究使用了包括15个连续视频帧的图像数据集,使用非放大白光成像(WLI)、蓝光/光成像(BLI)和链接彩色成像(LCI)捕获。使用金标准计算CAD-EYE原型成功检测的灵敏度和特异性,金标准由经验丰富的内窥镜医师注释的肿瘤病变图像数据集组成。结果:WLI、BLI和LCI组分别分析了620、679和682个ESCC数据集。WLI组ESCC检测的敏感性为85.9%[81.1% ~ 90.6%]、特异性为93.3% [90.8% ~ 95.7%],BLI组为97.6%[95.6% ~ 99.7%]、92.9% [90.6% ~ 95.3%],LCI组为96.6%[94.2% ~ 99.1%]、93.2%[91.0% ~ 95.5%]。WLI、BLI和LCI组pT1a ESCC的敏感性分别为85.3%、97.3%和97.2%。对于GN,分析了841个WLI和882个LCI数据集。WLI组GN检测的灵敏度为95.5%[92.8% ~ 98.1%],特异度为86.1%,特异度为85.4% [82.6% ~ 88.2%],LCI组GN检测的灵敏度为93.9%[91.1% ~ 96.7%],特异度为94.4%,特异度为93.9%[92.0% ~ 95.8%]。WLI组和LCI组pT1a早期胃癌的敏感性分别为93.8%和92.4%。结论:CAD-EYE原型在检测ESCC和GN方面表现出高灵敏度,突出了其作为临床应用工具的潜力。
{"title":"A Multicenter Pivotal Study on the Artificial Intelligence System for Neoplastic Lesions Detection in Upper Gastrointestinal Endoscopy","authors":"Seiichiro Abe,&nbsp;Yoshiyasu Kitagawa,&nbsp;Waku Hatta,&nbsp;Takao Maekita,&nbsp;Motohiko Kato,&nbsp;Akihito Nagahara,&nbsp;Hiroyuki Osawa,&nbsp;Osamu Dohi,&nbsp;Hirotaka Nakashima,&nbsp;Kazuhiro Furukawa,&nbsp;Shiro Oka,&nbsp;Tomoko Yokoyama,&nbsp;Toru Ito,&nbsp;Ichiro Oda","doi":"10.1111/den.70015","DOIUrl":"10.1111/den.70015","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This pivotal study aimed to evaluate the performance of the CAD-EYE prototype in identifying esophageal squamous cell carcinoma (ESCC) and gastric neoplasm (GN) for regulatory approval of the Pharmaceuticals and Medical Devices Agency in Japan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective study utilized image datasets comprising 15 consecutive video frames captured using non-magnifying white-light imaging (WLI), blue laser/light imaging (BLI), and linked color imaging (LCI). The sensitivity and specificity of the CAD-EYE prototype for successful detection were calculated using the gold standard, which consists of image datasets of neoplastic lesions annotated by experienced endoscopists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 620, 679, and 682 ESCC datasets were analyzed in the WLI, BLI, and LCI groups, respectively. The sensitivity and specificity of ESCC detection were 85.9% [81.1%–90.6%] and 93.3% [90.8%–95.7%] in the WLI group, 97.6% [95.6%–99.7%] and 92.9% [90.6%–95.3%] in the BLI group, and 96.6% [94.2%–99.1%] and 93.2% [91.0%–95.5%] in the LCI group. The sensitivities for pT1a ESCC were 85.3%, 97.3%, and 97.2% in the WLI, BLI, and LCI groups, respectively. For GN, 841 WLI and 882 LCI datasets were analyzed. The sensitivity, specificity, and specificity in the detection flag of GN detection were 95.5% [92.8%–98.1%], 86.1%, and 85.4% [82.6%–88.2%] in the WLI group, and 93.9% [91.1%–96.7%], 94.4%, and 93.9% [92.0%–95.8%] in the LCI group, respectively. The sensitivities for pT1a early gastric cancer were 93.8% and 92.4% in the WLI and LCI groups, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The CAD-EYE prototype demonstrated high sensitivity in detecting ESCC and GN, highlighting its potential as a promising tool for clinical applications.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"37 12","pages":"1306-1314"},"PeriodicalIF":4.7,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145042339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1